Tingting Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tingting Sun has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Xiao Hou
Department of Physical Education, Peking University, Beijing, China
3 shared publications - Bing Ruan
School of Sports Medicine and Rehabilitation, Beijing Sport University, Beijing, China
1 shared publication Hanyue Zhang
School of Physical Education, Northeast Normal University, Jilin, Changchun, China
1 shared publication- Huixuan Zhou
Department of Physical Fitness and Health, School of Sport Science, Beijing Sport University, Beijing, China
1 shared publication - Jinghua Qian
Key Laboratory of Exercise Rehabilitation Science of the Ministry of Education, Beijing Sport University, Beijing 100084, China
1 shared publication Jingjing Yu
Exercise and Physical Fitness Key Laboratory of Ministry of Education, Beijing Sport University, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 18 December 2025
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 26 (1)
Impact of scoliosis-specific exercises on adolescents with idiopathic scoliosis
This meta-analysis aimed to assess the therapeutic efficacy and impact on health-related quality of life (QoL) of physiotherapeutic scoliosis-specific exer
- 18 December 2025
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 26 (1)
Open AccessImpact of scoliosis-specific exercises on adolescents with idiopathic scoliosis
This meta-analysis aimed to assess the therapeutic efficacy and impact on health-related quality of life (QoL) of physiotherapeutic scoliosis-specific exer
- Open Access
- 18 September 2025
- Published by MDPI AG in Behavioral Sciences
- Vol. 15 (9) , 1272
Long-Term Exercise Interventions for Reducing Drug Craving in People with Drug Use Disorder: A Systematic Review and Meta-Analysis
Exercise is a promising intervention for reducing drug craving, but recent studies have shown inconsistent effects. This meta-analysis aims to evaluate the effect of exercise interventions on drug craving and identify the key exercise factors that affect its effectiveness. The literature was searched in four English databases. Two authors independently performed literature screening, data extraction, and quality assessment. Subgroup, sensitivity, and meta-regression analyses were conducted to explore potential heterogeneity. The results demonstrated that exercise (SMD = −0.74, 95% CI: −0.91, −0.58; p < 0.00001) was more effective than control groups in reducing drug craving among people with drug use disorder. Subgroup analyses demonstrated that aerobic (SMD = −0.79, 95% CI: −1.03, −0.54; p < 0.00001), multi-component (SMD = −0.96, 95% CI: −1.73, −0.18; p = 0.02), and mind–body exercise (SMD = −0.57, 95% CI: −0.88, −0.26; p = 0.0003) could significantly reduce drug craving, while resistance exercise (SMD = −0.59, 95% CI: −1.33, 0.16; p = 0.12) could not. Moreover, moderate (SMD = −0.77, 95% CI: −0.95, −0.58; p < 0.00001) and high-intensity exercise (SMD = −0.63, 95% CI: −1.08, −0.19; p = 0.006) were effective in reducing drug craving. In addition, regardless of intervention period, single-session duration, and weekly frequency, exercise could significantly reduce drug craving. This study indicates that exercise effectively reduces drug craving, with type and intensity as key factors affecting the effectiveness.
- 18 September 2025
- Published by MDPI AG in Behavioral Sciences
- Vol. 15 (9) , 1272
Open AccessLong-Term Exercise Interventions for Reducing Drug Craving in People with Drug Use Disorder: A Systematic Review and Meta-Analysis
Exercise is a promising intervention for reducing drug craving, but recent studies have shown inconsistent effects. This meta-analysis aims to evaluate the effect of exercise interventions on drug craving and identify the key exercise factors that affect its effectiveness. The literature was searched in four English databases. Two authors independently performed literature screening, data extraction, and quality assessment. Subgroup, sensitivity, and meta-regression analyses were conducted to explore potential heterogeneity. The results demonstrated that exercise (SMD = −0.74, 95% CI: −0.91, −0.58; p < 0.00001) was more effective than control groups in reducing drug craving among people with drug use disorder. Subgroup analyses demonstrated that aerobic (SMD = −0.79, 95% CI: −1.03, −0.54; p < 0.00001), multi-component (SMD = −0.96, 95% CI: −1.73, −0.18; p = 0.02), and mind–body exercise (SMD = −0.57, 95% CI: −0.88, −0.26; p = 0.0003) could significantly reduce drug craving, while resistance exercise (SMD = −0.59, 95% CI: −1.33, 0.16; p = 0.12) could not. Moreover, moderate (SMD = −0.77, 95% CI: −0.95, −0.58; p < 0.00001) and high-intensity exercise (SMD = −0.63, 95% CI: −1.08, −0.19; p = 0.006) were effective in reducing drug craving. In addition, regardless of intervention period, single-session duration, and weekly frequency, exercise could significantly reduce drug craving. This study indicates that exercise effectively reduces drug craving, with type and intensity as key factors affecting the effectiveness.
- Open Access
- 30 July 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (15) , 2163
Does Physical Activity Affect Clinical Symptoms and the Quality of Life of Mild-Infected Individuals with COVID-19 in China? A Cross-Sectional Study
Background: Few studies have identified the links between physical activity (PA), clinical symptoms, and the quality of life (QoL) among mildly infected individuals with COVID-19. This cross-sectional study aims to evaluate how PA levels before infections affect the infectious symptoms and the QoL in mildly infected patients with COVID-19. Methods: An online questionnaire link including participants’ sociodemographic and anthropometric characteristics, clinical symptoms during the COVID-19 infectious period, the QoL of the worst symptomatic day, and PA in the last seven days before COVID-19 infections was disclosed. Logistic regression and multiple linear regression analyses were applied to assess the relationships between PA levels in the last seven days before infections and COVID-19-related outcomes. The level of statistical significance was set at p < 0.05. Results: Compared to the low-PA-level group, the moderate-PA-level group presented a higher risk of headaches (OR = 1.34, 95% CI = 1.03 to 1.75, and p = 0.03) and the high-PA-level group presented a higher risk of muscle/body aches (OR = 1.42, 95% CI = 1.04 to 1.93, and p = 0.03). The adjusted linear regression analysis showed that no associations were found between PA levels in the last seven days before infections and the QoL index value on the worst symptomatic day (moderate-PA-level group: β = −0.04, and p = 0.08; high-PA-level group: β = −0.04, and p = 0.17). However, for the mobility and usual activities dimensions of EQ-5D-5L, the lower-PA-level group had a lower burden of QoL than the higher-PA-level group did on the worst-symptomatic day. Conclusions: Among mildly infected patients with COVID-19, a higher PA level is associated with a higher risk of experiencing clinical symptoms and a lower QoL.
- 30 July 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (15) , 2163
Open AccessDoes Physical Activity Affect Clinical Symptoms and the Quality of Life of Mild-Infected Individuals with COVID-19 in China? A Cross-Sectional Study
Background: Few studies have identified the links between physical activity (PA), clinical symptoms, and the quality of life (QoL) among mildly infected individuals with COVID-19. This cross-sectional study aims to evaluate how PA levels before infections affect the infectious symptoms and the QoL in mildly infected patients with COVID-19. Methods: An online questionnaire link including participants’ sociodemographic and anthropometric characteristics, clinical symptoms during the COVID-19 infectious period, the QoL of the worst symptomatic day, and PA in the last seven days before COVID-19 infections was disclosed. Logistic regression and multiple linear regression analyses were applied to assess the relationships between PA levels in the last seven days before infections and COVID-19-related outcomes. The level of statistical significance was set at p < 0.05. Results: Compared to the low-PA-level group, the moderate-PA-level group presented a higher risk of headaches (OR = 1.34, 95% CI = 1.03 to 1.75, and p = 0.03) and the high-PA-level group presented a higher risk of muscle/body aches (OR = 1.42, 95% CI = 1.04 to 1.93, and p = 0.03). The adjusted linear regression analysis showed that no associations were found between PA levels in the last seven days before infections and the QoL index value on the worst symptomatic day (moderate-PA-level group: β = −0.04, and p = 0.08; high-PA-level group: β = −0.04, and p = 0.17). However, for the mobility and usual activities dimensions of EQ-5D-5L, the lower-PA-level group had a lower burden of QoL than the higher-PA-level group did on the worst-symptomatic day. Conclusions: Among mildly infected patients with COVID-19, a higher PA level is associated with a higher risk of experiencing clinical symptoms and a lower QoL.